Polish Medical Translation Services

Yes. We have experience with URPL submissions and follow the Office's formatting requirements for Polish drug registration and marketing authorization dossiers.

Yes. We manage multi-site projects with dedicated project managers ensuring consistent terminology and formatting across all Polish trial locations.

Standard informed consent forms of 10 to 20 pages are typically completed within 2 to 3 business days, including QA. Urgent turnaround is available when the protocol timeline requires it.

Yes. The Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL) has specific Polish-language document structure and terminology requirements. Our Polish medical translators follow URPL formatting guidance for drug registration dossiers and the EU Clinical Trials Regulation requirements applicable to Polish sites. Polish clinical trial documentation also requires compliance with the Bioethics Committee (Komisja Bioetyczna) submission standards.

All translators and project managers sign GDPR-aligned data processing agreements before receiving any patient-identifiable material. Poland's UODO (Urzad Ochrony Danych Osobowych) implements EU GDPR requirements in Polish law; we apply these requirements as the baseline for all Polish health data projects. Files are transferred over encrypted channels and purged from our systems on project closure unless you request translation memory retention.